Table 1.
Demographic characteristics (n = 56)
| No. of patients (%) | |
|---|---|
| Age, median (range) | 66 years (1–87 years) |
| Gender | |
| Male | 41 (73.2%) |
| Female | 15 (26.8%) |
| Disease | |
| Malignant tumors | 54 (96.4%) |
| Craniopharyngioma | 1 (1.8%) |
| Cerebral arteriovenous malformation | 1 (1.8%) |
| Primary tumor | |
| Prostate | 17 (30.4%) |
| Bone/soft tissue | 10 (17.8%) |
| Liver | 7 (12.5%) |
| Lung | 6 (10.7%) |
| Central nervous system | 5 (8.9%) |
| Colon | 2 (3.6%) |
| Pancreas | 2 (3.6%) |
| Kidney | 2 (3.6%) |
| Others | 5 (8.9%) |
| Aim of treatment | |
| Curative | 52 (92.9%) |
| Palliative | 4 (7.1%) |
| Prescribed dose, median (range) | 65 GyE (20–76 GyE) |
| No. of fractions, median (range) | 26 (4–35) |
| Use of RGPT | 28 (50.0%) |
| Chemotherapy | |
| Concurrent | 1 (1.8%) |
| Adjuvant | 10 (17.9%) |